Background illustration for clinical trials search

Triple Negative Breast Cancer Clinical Trials

Browse 2,256 triple negative breast cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Topical Betamethasone Versus Moisturizer in Preventing Radiation Dermatitis in Large-Breasted Patients Treated in the Prone Position

for
Breast Cancer, Radiation Dermatitis
Location: Toronto
Sponsor: Sunnybrook Health Sciences Centre

Sex: All

Age: 18+

Code: NCT06915857

Phase 3, Recruiting

STABLE (Strength Training and Balance Leg Exercise) Study

for
Neoplasms
Location: Edmonton
Sponsor: University of Saskatchewan

Sex: All

Age: 65+

Code: NCT04518098

Recruiting

The Study of Biodistribution and Dosimetry of 99mTc-Glycopeptide(99mTc-GP) in Patients With Breast Cancer

for
Breast Cancer
Location: Houston TX
Sponsor: SeeCure LLC

Sex: All

Age: 18+

Code: NCT01159405

Phase 1, Recruiting

Occupational Cancer Screening in Firefighters: A Pilot Study Within the Inova Health System

for
Cancer
Location: Fairfax VA
Sponsor: Inova Health Care Services

Sex: All

Age: 35 - 70+

Code: NCT06931561

Recruiting

An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain Metastasis

for
Anatomic Stage IV Breast Cancer AJCC v8,
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT05376878

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

STING MARK Universal Fiducial Marker System

for
Cancer
Location: Montreal
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)

Sex: All

Age: 18+

Code: NCT05465161

Recruiting

Metformin for the Treatment of Insulin Resistance in Women With Stage I-III Breast Cancer Completing Chemotherapy

for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: Female

Age: 18+

Code: NCT06763328

Phase 3, Recruiting

Genomic Profiling in Recommending Treatment for Patients With Metastatic Solid Tumors

for
Unspecified Adult Solid Tumor, Protocol Specific
Location: Palo Alto CA
Sponsor: Stanford University

Sex: All

Age: 18+

Code: NCT02215928

Recruiting

Empowering Vulnerable and Resilient Latinas to Obtain Breast Cancer Care

for
Breast Cancer
Location: Chicago IL
Sponsor: University of Illinois at Chicago

Sex: Female

Age: 30+

Code: NCT05483283

Recruiting

BOLSTER: Learning New Skills to Thrive

for
Gastrointestinal Cancer, Gynecologic Cancer, Advanced Cancer
Location: Boston MA, Houston TX
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT06936878

Recruiting

A Study in Patients With Advanced Cancers

for
Advanced Cancer, Advanced Solid Tumor, Cancer, Oncology
Location: Fairfax VA, Houston TX, Austin TX
Sponsor: BiOneCure Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT05320588

Phase 1, Phase 2, Recruiting

Patient Reported Outcomes/Metrics Program Trial

for
Metastatic Cancer, Palliative
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT04983199

Recruiting

Randomized Feasibility Trial for Mesh in Pre-Pectoral Reconstruction

for
Breast Cancer,
Location: Los Angeles CA
Sponsor: University of California, Los Angeles

Sex: Female

Age: 22 - 70+

Code: NCT05190978

Recruiting

LANDscape MApping of Epitopes and T Cell Receptors for Selected Cancers

for
Solid Tumor
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT04665388

Recruiting

The Effect of COVID-19 Pandemic on Adolescent and Young Adult Cancer Patients and Survivors

for
COVID-19 Infection, Hematopoietic and Lymphoid Cell Neoplasm,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18 - 39

Code: NCT04551378

Recruiting

Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer

for
Brain Cancer, Glioblastoma, Metastatic Cancer,
Location: New York NY
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT06058988

Phase 2, Recruiting

Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Boston MA, Philadelphia PA, Fairfax VA, Houston TX,
Sponsor: Tagworks Pharmaceuticals BV

Sex: All

Age: 18+

Code: NCT06959706

Phase 1, Recruiting

A Study of SPX-303, a Bispecific Antibody Targeting LILRB2 and PD-L1 in Patients With Solid Tumors

for
Solid Tumor, HNSCC, RCC, CRC
Location: Jacksonville FL, Rochester MN, Scottsdale AZ,
Sponsor: SparX Biotech(Jiangsu) Co., Ltd.

Sex: All

Age: 18+

Code: NCT06259552

Phase 1, Recruiting

DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs

for
Breast Cancer, Breast Cancer Female,
Location: Boston MA, Durham NC, Miami FL
Sponsor: Nancy Lin, MD

Sex: All

Age: 18+

Code: NCT06176261

Phase 2, Recruiting

VS-6766+Abema+Fulv in Met HR+/HER- BC

for
Breast Cancer, Hormone Receptor-positive Breast Cancer,
Location: Boston MA
Sponsor: Adrienne G. Waks

Sex: All

Age: 18+

Code: NCT05608252

Phase 1, Phase 2, Recruiting

What is triple negative breast cancer?

Triple negative breast cancer, or TNBC, is breast cancer whose cells test negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so hormone therapy and HER2 targeted drugs do not work against it. It tends to grow faster and is more common in women who have not gone through menopause, in Black women, and in people with an inherited BRCA1 mutation, so genetic testing is recommended for everyone diagnosed. In US data, five year relative survival is about 92 percent when it is found while localized, 67 percent with regional spread, and 15 percent once it has reached distant organs. Standard treatment for early stage disease is chemotherapy combined with immunotherapy before surgery, followed by more treatment after; metastatic disease is treated with chemotherapy, immunotherapy for PD-L1 positive tumors, and antibody drug conjugates. Other breast cancers are covered on our breast cancer clinical trials page.

Types of triple negative breast cancer clinical trials

Who can participate in triple negative breast cancer clinical trials?

Is triple negative breast cancer hereditary?

Stages of triple negative breast cancer, and why they matter for trials

How to enroll in a triple negative breast cancer clinical trial